Corpus Intelligence IC Memo — J KENT MCNEW FAMILY MEDICAL CENTER 2026-04-26 09:35 UTC
IC Memo — J KENT MCNEW FAMILY MEDICAL CENTER
Investment Committee Memorandum | MD | 16 beds | Grade D | EBITDA uplift $541K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

J KENT MCNEW FAMILY MEDICAL CENTER

CCN 214020 | ANNE ARUNDEL, MD | 16 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

J KENT MCNEW FAMILY MEDICAL CENTER is a 16-bed community hospital in ANNE ARUNDEL, MD with $7.2M in net patient revenue and a -20.9% operating margin. The hospital serves a payer mix of 10.7% Medicare, 0.0% Medicaid, and 89.3% commercial.

Thesis: Turnaround. Our ML models identify $541K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -20.9% to -13.4% (+749bps).

Net Revenue HCRIS$7.2M
Current EBITDA COMPUTED$-1.5M
Operating Margin COMPUTED-20.9%
Occupancy HCRIS88.4%
Revenue / Bed COMPUTED$451K
Net-to-Gross HCRIS81.4%
Distress Probability MLnan%

2. Market Context & Competitive Position

59
MD Hospitals
-8.3%
State Median Margin
1875
Comparable Hospitals

MD has 59 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of -20.9% places it below the state median. Among 1875 size-comparable peers (8-32 beds), the median margin is -7.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-32), prioritizing same-state peers. 1875 hospitals in the comp set.

HospitalStateBedsRevenueMargin
J KENT MCNEW FAMILY MEDICAL CE (Target)MD16$7.2M-20.9%
DANA-FARBER CANCER INSTITUTEMA30$1.88B-35.1%
FRED HUTCHINSON CANCER CENTERWA20$1.17B-50.0%
MERCY WALWORTH HOSPITALWI25$616.4M4.4%
CORYELL MEMORIAL HOSPITALTX25$305.9M-1.5%
VALLEY VIEW HOSPITALCO31$285.3M-3.1%
WENATCHEE VALLEY HOSPITALWA11$277.5M-4.9%
TAHOE FOREST HOSPITALCA25$264.3M13.0%
PORTERVILLE DEVELOPMENTAL CENTCA17$193.6M-6.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $541K (749bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$152K+210bp18mo
Denial Rate Reduction12.0%6.5%$147K+204bp12mo
Cost to Collect4.5%2.5%$144K+200bp12mo
A/R Days Reduction5200.0%3800.0%$88K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+13bp6mo

5. EBITDA Bridge

Net Collection Rate
$152K
Denial Rate Reduction
$147K
Cost to Collect
$144K
A/R Days Reduction
$88K
Clean Claim Rate
$10K
Total EBITDA Uplift$541K
Current EBITDA$-1.5M
+ RCM Uplift+$541K
Pro Forma EBITDA$-967K
Current Margin-20.9%
Pro Forma Margin-13.4%
WC Released (1x)$277K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.3M$-4.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.3M$-5.7M0.00x-100.0%
Bull Case9.0x11.0x$-2.1M$-4.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.1M$-5.8M0.00x-100.0%
Bear Case11.0x10.0x$-2.6M$-6.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.6M$-8.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 1875 hospitals with 8-32 beds
  • Same-state prioritization (n=4)
  • Comp margins: P25=-20.0% / P50=-7.0% / P75=2.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.